Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting
November 7, 2022
November 7, 2022
November 4, 2022
November 3, 2022
November 3, 2022
November 1, 2022
October 5, 2022
September 5, 2022
September 1, 2022
August 11, 2022
August 4, 2022